Design, Synthesis, and Proposed Active Site Binding Analysis of Monocyclic 2-Azetidinone Inhibitors of Prostate Specific Antigen

Active Site ◽

Specific Antigen ◽

Design Synthesis ◽

Binding Analysis ◽

Site Binding

Structure-based design & synthesis of [alpha]-aminoalkylphosphonate esters for prostate-specific antigen inhibition

10.17918/etd-6359 ◽

2021 ◽

Author(s):

Arben Kojtari

Keyword(s):

Specific Antigen ◽

Design Synthesis

A new Approach to Active-Site Binding Analysis. Inhibitors of Acetylcholinesterase

Quantitative Structure-Activity Relationships ◽

10.1002/qsar.19900090304 ◽

1990 ◽

Vol 9 (3) ◽

pp. 202-215 ◽

Cited By ~ 7

Author(s):

Philip S. Magee

Keyword(s):

Active Site ◽

New Approach ◽

Binding Analysis ◽

Site Binding

Role of Multiparametric Magnetic Resonance Imaging Prostate Specific Antigen Density and PI-RADS™ Score in Predicting Up Staging in Men on Active Surveillance

Urology Practice ◽

10.1016/j.urpr.2018.05.007 ◽

2019 ◽

Vol 6 (2) ◽

pp. 117-122 ◽

Cited By ~ 1

Author(s):

Michelle Van Kuiken ◽

Robert H. Blackwell ◽

Bryan Bisanz ◽

Cara Joyce ◽

Joseph Yacoub ◽

...

Keyword(s):

Magnetic Resonance Imaging ◽

Magnetic Resonance ◽

Active Surveillance ◽

Specific Antigen ◽

Resonance Imaging ◽

Multiparametric Magnetic Resonance Imaging ◽

Prostate Specific Antigen Density

1721: The Observed Correlation between Testosterone Levels and Prostate Specific Antigen Values in a Large Screening Population

10.1016/s0022-5347(18)31909-8 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 573-573

Author(s):

E. David Crawford ◽

Colin O'Donnell ◽

Al B. Barqawi

Keyword(s):

Specific Antigen ◽

Testosterone Levels ◽

Screening Population

197: Prostate Cancer Screening Strategies with Rescreening Interval Determined by Individual Baseline Prostate-Specific Antigen Values are Cost-Effective

10.1016/s0022-5347(18)30462-2 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 66-66

Author(s):

Takashi Kobayashi ◽

Rei Goto ◽

Kazuto Ito ◽

Osamu Ogawa

Keyword(s):

Prostate Cancer ◽

Cancer Screening ◽

Prostate Cancer Screening ◽

Specific Antigen ◽

Cost Effective ◽

Screening Strategies

474: Prostate Specific Antigen (PSA) vs. Cancer Volume and High-Grade Cancer (PCA) Volume at Radical Prostatectomy (RP) in a Large European Cohort: Is the PSA Era Over in Europe as Well?

10.1016/s0022-5347(18)34727-x ◽

2005 ◽

Vol 173 (4S) ◽

pp. 130-130

Author(s):

Pierre I. Karakiewicz ◽

Paul Perrotte ◽

Thomas Steuber ◽

Alexander Haese ◽

Markus Graefen ◽

...

Keyword(s):

Radical Prostatectomy ◽

Specific Antigen ◽

High Grade

1489: When is Enough, Enough7-Benefit of Saturation Prostate Biopsy in Men with Previous Negative Biopsies and Persistently Elevated Prostate-Specific Antigen

10.1016/s0022-5347(18)33693-0 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 481-481

Author(s):

Timothy Kim ◽

Kamran Sajadi ◽

Ronald Lewis

Keyword(s):

Prostate Biopsy ◽

Specific Antigen ◽

Negative Biopsies

956: Evaluation of Human Glandular Kallikrein 2 and Free Prostate-Specific Antigen Levels as Predictors of Biochemical Recurrence after Radical Prostatectomy for Localized Prostate Cancer

10.1016/s0022-5347(18)35112-7 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 259-259

Author(s):

Thomas Steuber ◽

Alexander Haese ◽

Andrew J. Vickers ◽

Charlotte Becker ◽

Felix K.-H. Chun ◽

...

Keyword(s):

Prostate Cancer ◽

Radical Prostatectomy ◽

Biochemical Recurrence ◽

Specific Antigen ◽

Localized Prostate Cancer ◽

Glandular Kallikrein ◽

Kallikrein 2

36: Management of Patients with Elevated Prostate Specific Antigen Level among General Practitioners in Switzerland

10.1016/s0022-5347(18)34301-5 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 10-11

Author(s):

Markus Fatzer ◽

Michael Muentener ◽

Raeto T. Strebel ◽

Dieter Hauri ◽

Hubert A. John

Keyword(s):

General Practitioners ◽

Specific Antigen ◽

Prostate Specific Antigen Level ◽

Antigen Level

1143: Critical Analysis of Prostate Specific Antigen Doubling Time (PSADT) Calculation Methodology

10.1016/s0022-5347(18)35299-6 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 310-311

Author(s):

Robert S. Svatek

Keyword(s):

Critical Analysis ◽

Doubling Time ◽

Specific Antigen ◽

Calculation Methodology